Funding for this research was provided by:
National Key Scientific Instrument and Equipment Development Projects of China (2016YFC1303012)
National Basic Research Program of China (973 Program) (2015CB553903)
National Science-technology Supporting Plan Projects (2015BAI13B05)
Chinese National Key Plan of Precision Medicine Research (2016YFC0902901)
Nature and Science Foundation of China (81402163, 81402164, 81472783, 81572569, 81501530, 81671394, 81370469)
International S&T Cooperation Program of China (2013DFA31400)
Research Project of Health and Family Planning Commission of Hubei Province (WJ2015MA001)
Text and Data Mining valid from 2019-11-08
Received: 16 April 2019
Accepted: 24 October 2019
First Online: 8 November 2019
Ethics approval and consent to participate
: Primary cell lines and animal studies were approved by the Ethical Committee of the Medical Faculty of Tongji Medical College (Wuhan, China), and were performed according to the relevant guidelines and regulations. All procedures performed in studies were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors declare that they have no competing interests.